AK Medical Holdings Limited on 28 July 2026 issued a clarification regarding the exercise price for share options granted on 23 July 2026. The company confirmed that the correct exercise price is HK$5.85 per share, revising the HK$5.84 figure previously disclosed.
The exercise price was set at the highest of: 1. The closing price of HK$5.61 per share on the grant date (23 July 2026). 2. The five-day average closing price of HK$5.842 per share recorded from 16 July to 22 July 2026. 3. The nominal value of HK$0.01 per share.
All other terms in the original announcement remain unchanged. The clarification was authorised by Chairman Li Zhijiang on behalf of the Board, which currently comprises four executive directors, one non-executive director and three independent non-executive directors.